Bi-specific fusion proteins

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9982060
SERIAL NO

14187728

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Bi-specific fusion proteins with therapeutic uses are provided, as well as pharmaceutical compositions comprising such fusion proteins, and methods for using such fusion proteins to repair damaged tissue. The bi-specific fusion proteins generally comprise: (a) a targeting polypeptide domain that binds to an ischemia-associated molecule; and (b) an activator domain that that detectably modulates the activity of a cellular network.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SILVER CREEK PHARMACEUTICALS INC409 ILLINOIS STREET SAN FRANCISCO CA 94158

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
DeLaBarre, Byron Cambridge, US 29 245
Harms, Brian Roslindale, US 44 638
Linggi, Bryan Richland, US 11 103
Nielsen, Ulrik Bjerl Quincy, US 4 11
Onsum, Matthew Jamaica Plain, US 11 103
Schoeberl, Birgit Cambridge, US 24 363
Wickham, Thomas Groton, US 27 135

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Nov 29, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 29, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00